Rezension:
I\'m about to run out of credit order actos
\"This pre-screening will take Lilly longer to enroll patients, but is a wise move,\" Sanford Bernstein analyst Tim Anderson said in a research note. He said the earliest the drug is likely to reach the market, assuming the trial succeeds, is late 2017.
